Hepatitis C Virus (HCV) is a silent threat, claiming more lives from liver disease than alcohol in Mauritius, yet it often goes unnoticed by many. However, early detection can lead to highly effective treatment, allowing individuals to live normal lives thereafter.
Unfortunately, many people are unaware of their HCV diagnosis, underscoring the importance of screening and connecting individuals to care. Shockingly, WHO statistics reveal that over 60% of patients in sub-Saharan Africa are unaware of their status, and less than 20% receive treatment. HCV is commonly transmitted through contact with blood and bodily fluids, making intravenous drug users (IVDUs) particularly vulnerable.
However, stigma often complicates early detection and treatment for these individuals.
In 2018, only one hospital in Mauritius treated HCV patients. Recognizing the urgent need to meet the WHO target of HCV Elimination by 2030, we swiftly took action. Collaborating with doctors and NGOs, we expanded treatment access across the island to 21 points, including NGO sites, prisons, and methadone dispensing sites and also ensure rapid availability of HCV PCR results.
Regular Hepatitis C Training sessions ensure that healthcare professionals remain vigilant in encouraging screening and facilitating care linkage. This ongoing education guarantees that, despite staff turnover, all healthcare providers are well-versed in treatment protocols, maintaining consistent standards of care. Thanks to these efforts, over 2300 patients have received Hepatitis C treatment, with cure rates exceeding 98%, solidifying Mauritius as a leader in HCV treatment within sub-Saharan Africa.